Tag: FDA
CPHI annual report predicts AI to transform all processes in drug...
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Vieroots collaborates with AliveCor to enable ECG monitoring anytime, anywhere in...
AliveCor’s FDA-cleared KardiaMobile 6L device, the most clinically validated personal six lead ECG solution in the world, has been used by more than one million people
Concept Medical gets 4th IDE approval from USFDA for its MagicTouch...
Magic Touch PTA is the world’s first Sirolimus coated balloon with extensive commercial usage in Europe, major markets of Asia and the Mid-Eastern markets
Intrapartum monitoring devices market to reach US$ 4.5 Billion in 2032:...
Demand expanded significantly from 2015 to 2021, registering a growth rate of 7.5% to be valued at US$ 2.2 Billion
Parexel appoints Peyton Howell as Chief Operating & Growth Officer
The company has promoted FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence
Intrapartum Monitoring Devices market to reach US$ 4.5 Billion by 2032:...
As of 2022, the market is poised to reach US$ 2.3 Billion, yielding a dollar opportunity worth US$ 2.2 Billion throughout the forthcoming decade
FDA accords special status to prostate cancer blood test from Datar...
TriNetra-Prostate is based upon the detection of prostate adenocarcinoma specific Circulating Tumor Cells (CTCs) in the blood
Covid-19 vaccine booster dose could help mitigate the pandemic impact: Experts
India has achieved over 100 crore vaccinations but still only 38% of the population has achieved full vaccination. Major emphasis to be put on the frontline workers and the vulnerable population like elderly persons and children....................
Nanoparticles-based improved cancer drug could be in the offing
A team of scientists in India has developed nanoparticles called nanomicelles that are extremely small in size ranging from 10 to 100 nanometers and they serve as efficient systems through which the drugs can be delivered......................
New technology allows control of gene therapy doses
Technique appears to solve a major safety issue and could lead to much more use of gene therapies.....................